MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$893,369K Marketable securities$217,193K Prepaid expenses andother current assets$16,025K Property and equipmentatcost$32,750K Total current assets$1,126,587K Property and equipment,net$24,029K Right-of-use assets$20,742K Restricted cash and otherassets$15,600K Less accumulateddepreciation and...$8,721K Total assets$1,186,958K Total liabilities andstockholders equity$1,186,958K Total stockholdersequity$972,129K Total liabilities$214,829K Accumulated deficit-$1,396,142K Additional paid-in capital$2,367,780K Long-term debt, net$148,921K Total currentliabilities$50,625K Lease liabilities,net of current...$15,283K Accumulated othercomprehensive gain$475K Common stock, 0.0001par value...$16K Accrued expenses andother current...$37,548K Accounts payable$8,082K Lease liabilities$4,995K
Balance Sheet
source: myfinsight.com

Dyne Therapeutics, Inc. (DYN)

Dyne Therapeutics, Inc. (DYN)